Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation
- PMID: 9589080
- DOI: 10.1002/(sici)1096-911x(199806)30:6<319::aid-mpo1>3.0.co;2-h
Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation
Abstract
Background: Current controversies in pediatric intracranial ependymoma include histologic categorization and management. Most of our knowledge of this disease comes from single-institution reports.
Methods: A literature search was done, covering the period 1976-1996. The aim of this review is to analyze the prognostic factors reported in the literature over the last 20 years.
Results: Forty-five series were reviewed, including more than 1,400 children. The largest series reported on 92 patients, and the accrual rate ranged from 0.32-12 patients per year. None of the prognostic factors reported achieved a consensus throughout the different series. Histology remains a major issue, and the range in the incidence of anaplastic ependymo mas (7-89%) highlights the difficulty in agreeing on a histological grading system. The role of surgery on the outcome seems to be determinant. Recent series based on homogeneous imaging-documented extents of resection strongly support the benefit of postoperative radiotherapy. The lack of a proven, effective chemotherapy regimen precludes its use except in prospective pilot studies.
Conclusions: Limited information is available from single-institution reports in ependymoma. Only large national or international studies can provide enough information to allow a multivariate analysis of the prognostic factors, and thus lead to new therapeutic proposals.
Similar articles
-
The histologic grade is a main prognostic factor for patients with intracranial ependymomas treated in the microneurosurgical era: an analysis of 258 patients.Cancer. 2004 Mar 15;100(6):1230-7. doi: 10.1002/cncr.20075. Cancer. 2004. PMID: 15022291
-
Ependymal tumors in childhood.Pediatr Blood Cancer. 2005 Sep;45(3):298-303. doi: 10.1002/pbc.20212. Pediatr Blood Cancer. 2005. PMID: 15770637
-
Analysis on therapeutic outcomes and prognostic factors of intracranial ependymoma: a report of 49 clinical cases in a single center.Neurol Sci. 2015 Dec;36(12):2253-61. doi: 10.1007/s10072-015-2347-2. Epub 2015 Jul 28. Neurol Sci. 2015. PMID: 26216494
-
Advances in Management of Pediatric Ependymomas.Curr Oncol Rep. 2015 Oct;17(10):47. doi: 10.1007/s11912-015-0470-0. Curr Oncol Rep. 2015. PMID: 26369328 Review.
-
Intracranial ependymomas of childhood: current management strategies.Pediatr Neurosurg. 2000 Sep;33(3):138-50. doi: 10.1159/000028995. Pediatr Neurosurg. 2000. PMID: 11096361 Review.
Cited by
-
Genomic imbalances in pediatric intracranial ependymomas define clinically relevant groups.Am J Pathol. 2002 Dec;161(6):2133-41. doi: 10.1016/S0002-9440(10)64491-4. Am J Pathol. 2002. PMID: 12466129 Free PMC article.
-
Surgical management of supratentorial ependymomas.Childs Nerv Syst. 2009 Oct;25(10):1215-20. doi: 10.1007/s00381-009-0881-z. Epub 2009 Apr 9. Childs Nerv Syst. 2009. PMID: 19357853 Review.
-
Childhood ependymoma: a systematic review of treatment options and strategies.Paediatr Drugs. 2003;5(8):533-43. doi: 10.2165/00148581-200305080-00004. Paediatr Drugs. 2003. PMID: 12895136
-
Epigenomic analysis of Alu repeats in human ependymomas.Proc Natl Acad Sci U S A. 2010 Apr 13;107(15):6952-7. doi: 10.1073/pnas.0913836107. Epub 2010 Mar 29. Proc Natl Acad Sci U S A. 2010. PMID: 20351280 Free PMC article.
-
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.Br J Cancer. 2002 Mar 18;86(6):929-39. doi: 10.1038/sj.bjc.6600180. Br J Cancer. 2002. PMID: 11953826 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical